Global University Venturing

Oxford Nanopore has continued its funding streak with another $108m, bringing this year's haul to more than $208m and its overall total to around $800m.

MIT's cancer drug developer Kronos Bio floated above its range in an upsized offering and saw its shares soar in price post-IPO.

Galecto has filed to go public nine years after being founded in Sweden to commercialise research from Lund and Edinburgh universities.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Claudia Pingue, former Politecnico di Milano tech transfer manager, has taken on a leadership role at CDP's $177m spinout investment fund.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.

Nanopareil employs nanofibre membranes to separate chemical compounds for the purposes of purifying biopharmaceutical candidates.

Five-year commercialisation activity at the university is on the rise in terms of patents, inventions and licensing revenue.

University endowment-backed Will Ventures aims to unlock sports-related innovation across markets such as fitness, media and gaming.

UC Investments has backed cancer cell therapy developer A2 Biotherapeutics, bringing the company's total funding to $136m.